Product Description: Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce.

Product Features:

Product Name : Daclavir
Generic Name : Daclatasvir
Formulation : Tablet
Available Pack Size : 1×10’s
Available Strength : 60 mg
Registrations : Bangladesh